Integrated BioPharma, Inc. Stock Other OTC
Equities
INBP
US45811V1052
Pharmaceuticals
Financials (USD)
Sales 2022 | 56.25M | Sales 2023 | 50.67M | Capitalization | 9.92M |
---|---|---|---|---|---|
Net income 2022 | 3M | Net income 2023 | - | EV / Sales 2022 | 0.3 x |
Net Debt 2022 | 1.71M | Net Debt 2023 | 1.36M | EV / Sales 2023 | 0.22 x |
P/E ratio 2022 |
4.17
x | P/E ratio 2023 |
-292
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 20.22% |
Managers | Title | Age | Since |
---|---|---|---|
Riva Sheppard
CEO | Chief Executive Officer | 57 | 91-04-30 |
Christina Kay
CEO | Chief Executive Officer | 54 | 94-11-30 |
Dina Masi
DFI | Director of Finance/CFO | 63 | 05-11-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Christina Kay
CEO | Chief Executive Officer | 54 | 94-11-30 |
Damon Desantis
BRD | Director/Board Member | 56 | 22-06-19 |
Eric Friedman
BRD | Director/Board Member | 76 | 20-11-03 |
1st Jan change | Capi. | |
---|---|---|
+24.08% | 562B | |
-6.03% | 358B | |
+20.24% | 322B | |
+7.98% | 297B | |
+13.21% | 219B | |
+6.35% | 199B | |
-10.55% | 196B | |
-10.26% | 149B | |
-6.08% | 146B |